
TIBET AIM PHARM. INC. — Investor Relations & Filings
Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 北京植德律师事务所关于西藏易明西雅医药科技股份有限公司2025年年度股东会的法律意见书 | 2026-05-19 | Chinese | |
| 2025年年度股东会决议公告 | 2026-05-19 | Chinese | |
| 关于2024年限制性股票激励计划首次授予第一个解除限售期解除限售股份上市流通的提示性公告 | 2026-05-19 | Chinese | |
| 关于举办2025年度业绩说明会的公告 | 2026-05-08 | Chinese | |
| 2025年度独立董事述职报告(何德明) | 2026-04-27 | Chinese | |
| 2025年度内部控制审计报告 | 2026-04-27 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46566523 | 北京植德律师事务所关于西藏易明西雅医药科技股份有限公司2025年年度股东会的法律意见书 | 2026-05-19 | Chinese | ||
| 46565988 | 2025年年度股东会决议公告 | 2026-05-19 | Chinese | ||
| 46565380 | 关于2024年限制性股票激励计划首次授予第一个解除限售期解除限售股份上市流通的提示性公告 | 2026-05-19 | Chinese | ||
| 44488014 | 关于举办2025年度业绩说明会的公告 | 2026-05-08 | Chinese | ||
| 38419441 | 2025年度独立董事述职报告(何德明) | 2026-04-27 | Chinese | ||
| 38419439 | 2025年度内部控制审计报告 | 2026-04-27 | Chinese | ||
| 38419438 | 关于使用自有资金进行现金管理的公告 | 2026-04-27 | Chinese | ||
| 38419426 | 关于续聘2026年度会计师事务所的公告 | 2026-04-27 | Chinese | ||
| 38419424 | 董事会薪酬与考核委员会关于2024年限制性股票激励计划首次及预留授予第一个解除限售期解除限售条件成就的核查意见 | 2026-04-27 | Chinese | ||
| 38419419 | 关于原实际控制人业绩承诺实现情况的说明专项审核报告 | 2026-04-27 | Chinese | ||
| 38419390 | 关于2025年度利润分配预案的公告 | 2026-04-27 | Chinese | ||
| 38419381 | 2025年年度审计报告 | 2026-04-27 | Chinese | ||
| 38419119 | 2025年年度报告摘要 | 2026-04-27 | Chinese | ||
| 38419106 | 关于签署股权转让协议之补充协议(二)的公告 | 2026-04-27 | Chinese | ||
| 38419097 | 北京植德律师事务所关于西藏易明西雅医药科技股份有限公司2026年第二次临时股东会的法律意见书 | 2026-04-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIBET AIM PHARM. INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54828/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54828 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54828 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54828 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54828}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIBET AIM PHARM. INC. (id: 54828)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.